Ridgewood Investments’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,000
Closed -$7.2K 497
2025
Q2
$7.2K Buy
+1,000
New +$79.5K ﹤0.01% 555

Other funds holding MRK

Ridgewood Investments's MRK Position: Q2 2026 in Review

Ridgewood Investments reduced its Merck (MRK) stake by 12% in Q2 2026, selling an estimated $149K and leaving 9,440 shares worth $1.21M. The position accounts for 0.45% of the portfolio, ranked #69.

Ridgewood Investments first reported a position in MRK in Q4 2016 and has held it in 35 quarters since. The position peaked at $1.88M in Q3 2025. 1,976 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Ridgewood Investments held 9,440 shares of Merck worth $1.21M as of Q2 2026.
  • Ridgewood Investments sold 1,270 Merck shares in Q2 2026, an estimated $149K.
  • Merck made up 0.45% of Ridgewood Investments's portfolio in Q2 2026, its #69 holding.
  • Ridgewood Investments first reported a position in Merck in Q4 2016 and has held it in 35 quarters since.
  • Ridgewood Investments's Merck position peaked at $1.88M in Q3 2025.
  • 1,976 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Ridgewood Investments's 13F filing for Q2 2026, filed 3 Aug 2026.